- Home
- MIST vs ELMD Comparison
MIST vs ELMD Comparison
Compare MIST & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | ELMD |
|---|---|---|
| Founded | 2003 | 1992 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 208.1M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MIST | ELMD |
|---|---|---|
| Price | $1.50 | $35.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $8.00 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 1.4M | 41.2K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.55 |
| EPS | N/A | ★ 0.91 |
| Revenue | N/A | ★ $54,716,000.00 |
| Revenue This Year | $2,915.14 | $15.59 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | ★ N/A | $40.10 |
| Revenue Growth | N/A | ★ 13.83 |
| 52 Week Low | $1.00 | $17.73 |
| 52 Week High | $3.06 | $37.45 |
Technical Indicators
Market Signals| Indicator | MIST | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 33.77 | 78.39 |
| Support Level | $1.40 | $23.47 |
| Resistance Level | $2.01 | N/A |
| Average True Range (ATR) | 0.12 | 1.88 |
| MACD | -0.05 | 1.09 |
| Stochastic Oscillator | 6.36 | 84.20 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.